Kintor Pharma Jumps 12% on Hair-Loss Drug Filing
Kintor Pharma shares rose 12% intraday after its hair-loss drug filing.
Related stories
European stocks set to fall as oil rebounds on US-Iran tensions
Futures tracking the pan-European STOXX 600 slipped after reports of US strikes on Iran sent crude prices higher, weighing on hopes for an imminent end to the conflict.
M impact | EQUITY | Nov 03, 2026, 07:36 AM UTC
Abu Dhabi Islamic Bank Egypt Reports Q3 Attributable Profit of EGP 3.86 Billion
M impact | EQUITY | Nov 03, 2026, 07:27 AM UTC
JejuAir Swings to Q3 Operating Profit of KRW 54.9 Billion
JejuAir reported operating profit of KRW 54.9 billion in the third quarter of 2026.
M impact | EQUITY | Nov 03, 2026, 07:23 AM UTC
DL Holdings Raises Subsidiary’s Data Center Contract Value to KRW 936.11 Billion
M impact | EQUITY | Nov 03, 2026, 07:23 AM UTC
Europe Stocks Set to Fall as US-Iran Tensions Fuel Oil Rebound
European stocks were expected to fall as US-Iran tensions fueled a rebound in oil prices.
M impact | EQUITY | Nov 03, 2026, 07:20 AM UTC
Apple Reports Stronger-Than-Expected Fiscal Q3 Revenue
Apple's fiscal third-quarter revenue exceeded expectations, giving new CEO John Ternus an upbeat start to his tenure, which began in September.
M impact | EQUITY | Nov 03, 2026, 07:20 AM UTC